These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28238902)

  • 21. Oronasal and Tracheostomy Delivery of Soft Mist and Pressurized Metered-Dose Inhalers With Valved Holding Chamber.
    Berlinski A; Cooper B
    Respir Care; 2016 Jul; 61(7):913-9. PubMed ID: 27006348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Considerations for Designing In Vitro Bioequivalence (IVBE) Studies for Pressurized Metered Dose Inhalers (pMDIs) with Spacer or Valved Holding Chamber (S/VHC) Add-on Devices.
    Sandell D; Mitchell JP
    J Aerosol Med Pulm Drug Deliv; 2015 Jun; 28(3):156-81. PubMed ID: 25089555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Spacer, Aerosol Therapy through Space and Time].
    Voshaar T; Haidl P; Clös RM
    Laryngorhinootologie; 2019 Dec; 98(12):845-860. PubMed ID: 31810103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The evolution of spacers and valved holding chambers.
    Nikander K; Nicholls C; Denyer J; Pritchard J
    J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27 Suppl 1():S4-23. PubMed ID: 25054481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Computational analyses of a pressurized metered dose inhaler and a new drug-aerosol targeting methodology.
    Kleinstreuer C; Shi H; Zhang Z
    J Aerosol Med; 2007; 20(3):294-309. PubMed ID: 17894536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aerosol profile extracted from spacers as a determinant of actual dose.
    Verbanck S; Vervaet C; Schuermans D; Vincken W
    Pharm Res; 2004 Dec; 21(12):2213-8. PubMed ID: 15648252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro performance characteristics of valved holding chamber and spacer devices with a fluticasone metered-dose inhaler.
    Asmus MJ; Liang J; Coowanitwong I; Hochhaus G
    Pharmacotherapy; 2004 Feb; 24(2):159-66. PubMed ID: 14998215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A review of the in vitro and in vivo valved holding chamber (VHC) literature with a focus on the AeroChamber Plus Flow-Vu Anti-static VHC.
    Dissanayake S; Suggett J
    Ther Adv Respir Dis; 2018; 12():1753465817751346. PubMed ID: 29378477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of spacers on the delivery of metered dose aerosols of nedocromil sodium and disodium cromoglycate.
    Chew NY; Chan HK
    Int J Pharm; 2000 Apr; 200(1):87-92. PubMed ID: 10845689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The interaction between the oropharyngeal geometry and aerosols via pressurised metered dose inhalers.
    Ehtezazi T; Saleem I; Shrubb I; Allanson DR; Jenkinson ID; O'Callaghan C
    Pharm Res; 2010 Jan; 27(1):175-86. PubMed ID: 19902336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A non-electrostatic spacer for aerosol delivery.
    Bisgaard H; Anhøj J; Klug B; Berg E
    Arch Dis Child; 1995 Sep; 73(3):226-30. PubMed ID: 7492160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvement in sodium cromoglycate delivery from a spacer device by use of an antistatic lining, immediate inhalation, and avoiding multiple actuations of drug.
    O'Callaghan C; Lynch J; Cant M; Robertson C
    Thorax; 1993 Jun; 48(6):603-6. PubMed ID: 8346488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spacer devices for metered dose inhalers.
    Newman SP
    Clin Pharmacokinet; 2004; 43(6):349-60. PubMed ID: 15086274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimizing the primary particle size distributions of pressurized metered dose inhalers by using inkjet spray drying for targeting desired regions of the lungs.
    Ehtezazi T; Davies MJ; Seton L; Morgan MN; Ross S; Martin GD; Hutchings IM
    Drug Dev Ind Pharm; 2015 Feb; 41(2):279-91. PubMed ID: 24252108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of formulation and spacer device on the in vitro performance of solution chlorofluorocarbon-free propellant-driven metered dose inhalers.
    Smyth HD; Beck VP; Williams D; Hickey AJ
    AAPS PharmSciTech; 2004 Feb; 5(1):E7. PubMed ID: 15198528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel method of characterizing medicinal drug aerosols generated from pulmonary drug delivery devices.
    Ali M
    PDA J Pharm Sci Technol; 2010; 64(4):364-72. PubMed ID: 21502037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative in vitro performance of three small-volume valved holding chambers with beclomethasone/formoterol pressurized metered dose inhaler.
    Goncalves TM; Alhanout K; Nicolay A; Dubus JC; de Santana DP; Andrieu V
    J Aerosol Med Pulm Drug Deliv; 2013 Aug; 26(4):223-7. PubMed ID: 23094686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of actuator nozzle designs on the electrostatic charge generated in pressurised metered dose inhaler aerosols.
    Chen Y; Young PM; Fletcher DF; Chan HK; Long E; Lewis D; Church T; Traini D
    Pharm Res; 2015 Apr; 32(4):1237-48. PubMed ID: 25270573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Critical evaluation of inhalation spacer devices available in France].
    Gachelin E; Vecellio L; Dubus JC; ;
    Rev Mal Respir; 2015 Sep; 32(7):672-81. PubMed ID: 26163392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of actuator materials and nozzle designs on electrostatic charge of pressurised metered dose inhaler (pMDI) formulations.
    Chen Y; Young PM; Fletcher DF; Chan HK; Long E; Lewis D; Church T; Traini D
    Pharm Res; 2014 May; 31(5):1325-37. PubMed ID: 24297072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.